Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Joshua Mitchell, MD, Benedicte Lefebvre, MD and Vlad Zaha, MD, PhD share their experiences leading successful cardio-oncology fellowship programs and the future of cardio-oncology education and training. Moderated by Nicholas Wilcox, MD, MHS.

Anja Karlstaedt, MD, PhD discusses how cardiac metabolism, including SGLT2-inhibitors and GLP-1 receptor agonists, may inform cardioprotective strategies in cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.

Satish Ramkumer, MD, and Daniel Chen, MD, share their experiences starting a cardio-oncology service in Australia. Moderated by Alexandra Murphy, MD, PhD.

Commentary by Dr. Edward Gerstenfeld

Commentary by Drs. Pratik Doshi and Marat Fudim discussing new therapies and devices to better understand volume status in heart failure patients.

Bingcheng Liu, MD, Yuchao Guo, MD and Daniel Wang, MD discuss commonly asked questions related to radial access.

Nilay Shah, MD and Neeja Patel, MD discuss cardiometabolic health screening, pregnancy complications and increasing CVD burden in the Asian American population.

Audio Summary of the January 1, 2024 Issue by Dr. Jian'an Wang

Drs. Mary Norine Walsh, Kathryn Lindley, and Lindsay Panah discuss the JACC: Case Reports Special Issue on Cardio-Obstetrics

Commentary by Dr. Mirza Umair Khalid and Drs. Astrid C. van Nieuwkerk and Hugo M. Aarts

Commentary by Dr. Mirza Umair Khalid and Dr. Duk-Woo Park

Commentary by Dr. Mirza Umair Khalid and Dr. Taishi Okuno

Commentary by Dr. Mirza Umair Khalid and Dr. Ander Regueiro

Commentary by Social Media Editor Anju Bhardwaj